Free Trial

Elekta AB (OTCMKTS:EKTAY) Declares $0.07 Dividend

Elekta logo with Medical background

Key Points

  • Elekta AB has declared a dividend of $0.07 per share, with the ex-dividend date set for September 8th and payment to shareholders on September 26th.
  • The company's stock price is down by 2.2%, closing at $4.82, with a market cap of $1.77 billion.
  • Elekta reported $0.03 earnings per share for the last quarter, along with a revenue of $379.64 million and a net margin of 1.40%.
  • Five stocks we like better than Elekta.

Elekta AB (OTCMKTS:EKTAY - Get Free Report) declared a dividend on Wednesday, September 3rd, investing.com reports. Investors of record on Tuesday, September 9th will be paid a dividend of 0.0744 per share on Friday, September 26th. This represents a yield of 289.0%. The ex-dividend date of this dividend is Monday, September 8th.

Elekta Price Performance

Elekta stock traded up $0.03 during trading on Monday, reaching $4.82. The company had a trading volume of 1,448 shares, compared to its average volume of 12,740. The firm's 50-day simple moving average is $4.97 and its 200 day simple moving average is $5.11. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.86 and a current ratio of 1.09. The firm has a market capitalization of $1.78 billion, a PE ratio of 80.35 and a beta of 1.10. Elekta has a 1-year low of $4.36 and a 1-year high of $7.13.

Elekta (OTCMKTS:EKTAY - Get Free Report) last issued its quarterly earnings data on Thursday, August 28th. The company reported $0.03 earnings per share (EPS) for the quarter. Elekta had a net margin of 1.40% and a return on equity of 11.50%. The firm had revenue of $379.64 million for the quarter. As a group, equities research analysts anticipate that Elekta will post 0.36 earnings per share for the current fiscal year.

Elekta Company Profile

(Get Free Report)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.

Recommended Stories

Dividend History for Elekta (OTCMKTS:EKTAY)

Should You Invest $1,000 in Elekta Right Now?

Before you consider Elekta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elekta wasn't on the list.

While Elekta currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.